The mission of the Cancer Therapeutics and Host Response Research Program is to advance understanding of interactions between tumor cells, immune cells, and microbiota that mediate tumor development, progression and host responses, and to develop therapeutics that capitalize on these mechanisms and interactions.
132 members from seven colleges and 31 departments/schools
- Develop novel immunotherapies for refractory cancer
- Elucidate microbiome function in cancer development and therapeutics
- Identify and validate targeted therapeutics engaging key cancer pathways with small molecules and test new therapies in clinical trials